MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

5 Medical Technologies Fit for Football—Quanterix

Article-5 Medical Technologies Fit for Football—Quanterix



Lexington, MA-based Quanterix has developed the Simoa platform, which performs extremely sensitive automated detection and quantification of protein biomarkers. This includes blood biomarkers related to brain injury. 

Quanterix was recognized as one of six final winners in the Head Health Challenge I, sponsored by the NFL and GE, for its efforts to speed diagnosis of mild traumatic brain injuries. 

This summer, Quanterix announced a partnership with fellow winner Banyan Biomarkers that would add Banyan's UCH-L1 and GFAP assays for TBI biomarkers to its Simoa platform.


[Image courtesy of QUANTERIX]  

Learn about "Tapping the Explosion of Offerings in Sensors" at the MD&M Minneapolis Conference, September 21-22.
Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.